BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30728346)

  • 21. Ileal interposition reduces blood glucose levels and decreases insulin resistance in a type 2 diabetes mellitus animal model by up-regulating glucagon-like peptide-1 and its receptor.
    Sun X; Zheng M; Song M; Bai R; Cheng S; Xing Y; Yuan H; Wang P
    Int J Clin Exp Pathol; 2014; 7(7):4136-42. PubMed ID: 25120793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GLP-1 mediated improvement of the glucose tolerance in the T2DM GK rat model after massive jejunal resection.
    Prada-Oliveira JA; Camacho-Ramirez A; Salas-Alvarez J; Campos-Martinez FJ; Lechuga-Sancho AM; Almorza-Gomar D; Blandino-Rosano M; Perez-Arana GM
    Ann Anat; 2019 May; 223():1-7. PubMed ID: 30721719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is defective pancreatic beta-cell mass environmentally programmed in Goto-Kakizaki rat model of type 2 diabetes?: insights from crossbreeding studies during suckling period.
    Calderari S; Gangnerau MN; Meile MJ; Portha B; Serradas P
    Pancreas; 2006 Nov; 33(4):412-7. PubMed ID: 17079948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asiatic acid mitigates hyperglycemia and reduces islet fibrosis in Goto-Kakizaki rat, a spontaneous type 2 diabetic animal model.
    Wang X; Lu Q; Yu DS; Chen YP; Shang J; Zhang LY; Sun HB; Liu J
    Chin J Nat Med; 2015 Jul; 13(7):529-34. PubMed ID: 26233843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influences of exendin-4 on the secretion function of islet beta cells from rats in the early stage of severe scald].
    Zhao DX; Ma L; Shen ZA; Li DW; Shang YR; Yin K; Cheng WF; Wang X; Liu ZX
    Zhonghua Shao Shang Za Zhi; 2016 Dec; 32(12):752-758. PubMed ID: 28043300
    [No Abstract]   [Full Text] [Related]  

  • 27. On the role of the gut in diabetic hyperglucagonaemia.
    Lund A
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced Glucose Tolerance and Pancreatic Beta Cell Function by Low Dose Aspirin in Hyperglycemic Insulin-Resistant Type 2 Diabetic Goto-Kakizaki (GK) Rats.
    Amiri L; John A; Shafarin J; Adeghate E; Jayaprakash P; Yasin J; Howarth FC; Raza H
    Cell Physiol Biochem; 2015; 36(5):1939-50. PubMed ID: 26202354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes.
    Tanday N; English A; Lafferty RA; Flatt PR; Irwin N
    Front Endocrinol (Lausanne); 2021; 12():674704. PubMed ID: 34054734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-1 receptor antagonist improves normoglycemia and insulin sensitivity in diabetic Goto-Kakizaki-rats.
    Akash MS; Rehman K; Sun H; Chen S
    Eur J Pharmacol; 2013 Feb; 701(1-3):87-95. PubMed ID: 23348707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats.
    Pacheco D; de Luis DA; Romero A; González Sagrado M; Conde R; Izaola O; Aller R; Delgado A
    Am J Surg; 2007 Aug; 194(2):221-4. PubMed ID: 17618808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of New Modified Biliopancreatic Diversion on Blood Glucose and Lipids in GK rats.
    Weng S; Zhang B; Xu C; Feng S; He H
    Obes Surg; 2017 Mar; 27(3):657-664. PubMed ID: 27525641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats.
    Feigh M; Andreassen KV; Neutzsky-Wulff AV; Petersen ST; Hansen C; Bay-Jensen AC; Henriksen JE; Beck-Nielsen H; Christiansen C; Henriksen K; Karsdal MA
    Br J Pharmacol; 2012 Sep; 167(1):151-63. PubMed ID: 22506938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion.
    Salehi M; Vahl TP; D'Alessio DA
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4909-16. PubMed ID: 18827000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastric Bypass-Related Effects on Glucose Control, β Cell Function and Morphology in the Obese Zucker Rat.
    Seyfried F; Miras AD; Rotzinger L; Nordbeck A; Corteville C; Li JV; Schlegel N; Hankir M; Fenske W; Otto C; Jurowich C
    Obes Surg; 2016 Jun; 26(6):1228-36. PubMed ID: 26377340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of TS-021 with metformin improves hyperglycemia and synergistically increases pancreatic β-cell mass in a mouse model of type 2 diabetes.
    Tajima A; Hirata T; Taniguchi K; Kondo Y; Kato S; Saito-Hori M; Ishimoto T; Yamamoto K
    Life Sci; 2011 Oct; 89(17-18):662-70. PubMed ID: 21872612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of an olive oil-enriched diet on glucagon-like peptide 1 release and intestinal content, plasma insulin concentration, glucose tolerance and pancreatic insulin content in an animal model of type 2 diabetes.
    Cancelas J; Prieto PG; Villanueva-Peñacarrillo ML; Valverde I; Malaisse WJ
    Horm Metab Res; 2006 Feb; 38(2):98-105. PubMed ID: 16523410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of glucagon-like peptide-1-(7-36)-amide on pancreatic islet and intestinal blood perfusion in Wistar rats and diabetic GK rats.
    Svensson AM; Ostenson CG; Efendic S; Jansson L
    Clin Sci (Lond); 2007 Jun; 112(6):345-51. PubMed ID: 17087662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
    Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
    Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.